MX2024015341A - Derivados de 1,4-bis-(2-hidroxi-bencil)-1,4,7-triazaciclononano y compuestos similares como ligandos en complejos de hierro(iii) para su uso como agentes de contraste de resonancia magnetica - Google Patents

Derivados de 1,4-bis-(2-hidroxi-bencil)-1,4,7-triazaciclononano y compuestos similares como ligandos en complejos de hierro(iii) para su uso como agentes de contraste de resonancia magnetica

Info

Publication number
MX2024015341A
MX2024015341A MX2024015341A MX2024015341A MX2024015341A MX 2024015341 A MX2024015341 A MX 2024015341A MX 2024015341 A MX2024015341 A MX 2024015341A MX 2024015341 A MX2024015341 A MX 2024015341A MX 2024015341 A MX2024015341 A MX 2024015341A
Authority
MX
Mexico
Prior art keywords
iii
complexes
contrast agents
ligands
benzyl
Prior art date
Application number
MX2024015341A
Other languages
English (en)
Spanish (es)
Inventor
Mauro Botta
Lorenzo Tei
Fabio Carniato
Zsolt Baranyai
Mariangela Boccalon
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of MX2024015341A publication Critical patent/MX2024015341A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2024015341A 2022-07-28 2024-12-10 Derivados de 1,4-bis-(2-hidroxi-bencil)-1,4,7-triazaciclononano y compuestos similares como ligandos en complejos de hierro(iii) para su uso como agentes de contraste de resonancia magnetica MX2024015341A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22187403 2022-07-28
PCT/EP2023/071027 WO2024023314A1 (en) 2022-07-28 2023-07-28 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents

Publications (1)

Publication Number Publication Date
MX2024015341A true MX2024015341A (es) 2025-02-10

Family

ID=82780974

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024015341A MX2024015341A (es) 2022-07-28 2024-12-10 Derivados de 1,4-bis-(2-hidroxi-bencil)-1,4,7-triazaciclononano y compuestos similares como ligandos en complejos de hierro(iii) para su uso como agentes de contraste de resonancia magnetica

Country Status (10)

Country Link
US (1) US12358880B2 (enExample)
EP (1) EP4561995B1 (enExample)
JP (1) JP2025524769A (enExample)
KR (1) KR20250040575A (enExample)
CN (1) CN119343336A (enExample)
AU (1) AU2023313342A1 (enExample)
CA (1) CA3252691A1 (enExample)
IL (1) IL317339A (enExample)
MX (1) MX2024015341A (enExample)
WO (1) WO2024023314A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025163025A1 (en) 2024-01-31 2025-08-07 Bracco Imaging Spa Pyridophane macrocyclic ligands and fe(iii) complexes thereof
CN119499407B (zh) * 2024-11-25 2026-04-07 中国科学院精密测量科学与技术创新研究院 一种Fe基T7肽靶向脑胶质瘤小分子磁共振造影剂及其制备合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3624859A4 (en) 2017-05-19 2021-03-03 The Research Foundation for The State University of New York COMPOUNDS FOR USE AS IRON (III) MRT CONTRAST AGENTS
EP3880635B1 (en) 2018-11-12 2023-01-04 Bracco Imaging SPA Chelating aazta conjugate, complexes thereof and use

Also Published As

Publication number Publication date
IL317339A (en) 2025-01-01
AU2023313342A1 (en) 2024-12-19
JP2025524769A (ja) 2025-08-01
EP4561995B1 (en) 2026-05-27
WO2024023314A1 (en) 2024-02-01
US20250163007A1 (en) 2025-05-22
EP4561995A1 (en) 2025-06-04
US12358880B2 (en) 2025-07-15
CA3252691A1 (en) 2024-02-01
EP4561995C0 (en) 2026-05-27
CN119343336A (zh) 2025-01-21
KR20250040575A (ko) 2025-03-24

Similar Documents

Publication Publication Date Title
MX2023010737A (es) Nuevo agente de contraste para utilizar en imagenes por resonancia magnetica.
PE20180261A1 (es) Nuevos compuestos de quelato de gadolinio para usar en imagenes de resonancia magnetica
Caravan et al. Water exchange in lanthanide complexes for MRI applications. Lessons learned over the last 25 years
DE69527759D1 (de) Mono -und multimere verbindungen mit erhöhter relaxation
Boros et al. Gd (DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents
RU2017116176A (ru) Конъюгированные бисфосфонаты для диагностики и терапии заболеваний костей
DE69425572D1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
NZ335610A (en) Phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazole compounds useful as neuro-protective agents
ATE159522T1 (de) Fluorhaltige makrocyclische metallkomplexe
ATE493410T1 (de) Neue verbindung mit affinität zu amyloid
DOP2025000064A (es) Proceso para la preparación de un agente de contraste de gadolinio
MX2024012884A (es) Compuestos de liberacion de gamma-hidroxibutirato y procesos para fabricar y usar los mismos
JP2020520998A5 (enExample)
ATE365170T1 (de) Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden
Guanci et al. Synthesis of phosphonic analogues of AAZTA and relaxometric evaluation of the corresponding Gd (III) complexes as potential MRI contrast agents
RU2019118365A (ru) Хелатные соединения марганца на основе тетраазабицикло-макроцикла, подходящие в качестве визуализирующих агентов для MRI
TNSN06142A1 (en) Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
Zhang et al. Synthesis and relaxation properties of two non-ion complexes of gadolinium (III) and manganese (II) with derivatives from diethylene triamine pentaacetic acid and isoniazid
Martinelli et al. Selective functionalization of 6-amino-6-methyl-1, 4-perhydrodiazepine for the synthesis of a library of polydentate chelators
ES2541787A1 (es) Compuestos y composiciones que comprenden nanotubos de carbono y compuestos de formula (I) y su uso como agentes de contraste
CO5261508A1 (es) Compuestos bi-basicos como inhibidores de triptasa, procedimiento para su preparacion y su utilizacion como medicamentos
BR112022012292A2 (pt) Complexos de ferro e seus sais como agentes de contraste para mri
JP7584803B2 (ja) 抗微生物剤
WO2002026267A3 (en) Manganes complexes for magnetic resonance imaging
AR047264A1 (es) Nitrooxiderivados de drogas antihipertensivas